– Reassure Pregnancy is being used to monitor signs of pre-eclampsia in two NHS hospitals –
– Camgenium is pioneering the development of software to ensure high-quality antenatal care is accessible to all women –
Thursday 26th June 2025, Cambridge, UK – Camgenium, a leading medical device software company, has announced that its software product, ‘Reassure Pregnancy’, can improve outcomes for pregnant women at risk of pre-eclampsia through at-home monitoring. The Reassure Pregnancy system allows women to proactively monitor their symptoms at home using a simple app. Data is shared in real…
Cancer Research Horizons, the innovation arm of Cancer Research UK, has appointed its first Clinical Advisory Board to provide strategic guidance on the development of novel cancer therapeutics emerging from its drug discovery division, Therapeutic Innovation.
The Clinical Advisory Board brings together world-leading oncologists with expertise in early-phase clinical trials. The board will assess the clinical positioning and utility of drug discovery projects, ensuring that medical need and patient impact are central to decision-making from the earliest stages of target selection.
The…
Devens, MA, USA — Veranova is pleased to announce the appointment of Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides. Dr. Villain will bring extensive expertise in peptide and oligonucleotide development and manufacturing to Veranova as the company continues to strengthen its position as a key player in the Peptide and Oligonucleotide (TIDES) space.
“Dr. Villain, and his holistic experience in the development and manufacturing of peptide APIs, will be a tremendous asset to Veranova,” says Rohtash Kumar, Senior Vice President of Development Operations and Chief…
Amsbio, in association with Nordmark Biochemicals, has expanded its range of Collagenase and Neutral Protease NB enzymes with GMP grade formats and protocols to support advanced tissue dissociation workflows for applications from research to clinical use.
These enzymes, derived from Clostridium histolyticum, are critical raw materials for isolating viable cells from complex tissues - an essential step in tissue engineering, cell therapy and regenerative medicine. Their clinical relevance is reinforced by recent studies to set up a protocol for isolation, manufacturing, and…
Financing led by Ahren Innovation Capital with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures
Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and progress in-house target development program
Cambridge, UK, 24 June 2025: OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced it has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical…
The June edition of our People Pathways newsletter is available to read here!
Featuring:
✅ One Nucleus upcoming courses
✅ Training Course Spotlight: Introduction to Drug Development
✅ Practical Application of Toxicology in Drug Development 2025
Gastronomica, Pioneer Group’s cutting-edge food tech hub, was crowned winner of the Innovative Workplace Design award at the Property Week and Construction News Life Sciences & Research Clusters Awards.
The Awards celebrated excellence in real estate design and delivery across the life sciences and research sectors, with winners announced at a gala evening at the Hilton Bankside, London on 24 June 2025.
Chosen from a strong field, the judges praised Gastronomica’s clear vision to create a purpose-built cluster featuring sector-specific workspaces. They highlighted the hospitality-inspired…
Creative Biolabs stands as a powerhouse of antibody engineering expertise, whose end-to-end humanization platform is turning xenogeneic antibodies into preclinical frontrunners.A Ludwig Cancer Research team has cracked a metabolic code tumors use to evade immune attack, unveiling a humanized antibody that reignites anti-cancer immunity in resistant liver cancers, which was published in Cancer Discovery. The CD36-blocking antibody PLT012 overcomes lipid-driven immunosuppression, which is a game-changer for tumors exploiting fatty microenvironments. The breakthrough underscores a…
Sandwich, UK - 23 June 2025: Discovery Park opened its doors for the East Kent Science Jamboree, hosting a record-breaking 1,500 children from 51 Kent schools for a two day science spectacular.
This year's 30th anniversary celebration was the largest ever jamboree and marked a decade of the summit taking place at Sandwich science hub Discovery Park. Led by the STEM Hub at Canterbury Christ Church University and supported by Pfizer, the inspirational day introduced school pupils to science in action and demonstrated how STEM subjects impact everyday life.
The three-decade long science…
June 19, 2025
Devens, MA, USA — Government officials, industry leaders, and local business representatives gathered yesterday to mark the groundbreaking of Veranova’s latest expansion at its Devens, Massachusetts facility.
First announced in June 2024, the investment will add 9,000 square feet to the site, including a new state-of-the-art process development laboratory and two current Good Manufacturing Practice (cGMP) suites. These new capabilities will expand the site’s development and production capabilities for potent compounds, ADC linker-payloads, and other complex molecules critical to…